African Americans with oropharyngeal carcinoma have significantly poorer outcomes despite similar rates of human papillomavirus-mediated carcinogenesis

Human Pathology

Volumn 45, Issue 2, 2014, Pages 310-319

  Isayeva, Tatyana ^a   Xu, Jie ^a   Dai, Qian ^a   Whitley, Alex C ^a   Bonner, James ^a   Nabell, Lisle ^a   Spencer, Sharon ^a   Carroll, William ^a   Jones, Giera ^b   Ragin, Camille ^b   Brandwein Gensler, Margaret ^a  

^a The University of Alabama at Birmingham   (United States)

^b TEMPLE UNIVERSITY   (United States)

Author keywords

African Americans; Disparity; HPV; Oropharyngeal; Oropharynx; Outcome; p16

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLIN DEPENDENT KINASE INHIBITOR 2A; MESSENGER RNA;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CARCINOGENESIS; CAUCASIAN; CHEMORADIOTHERAPY; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DISEASE COURSE; DISEASE SPECIFIC SURVIVAL; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; OROPHARYNX CARCINOMA; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; RACE DIFFERENCE; REVERSE TRANSCRIPTION;

AFRICAN AMERICANS; DISPARITY; HPV; OROPHARYNGEAL; OROPHARYNX; OUTCOME; P16;

ADULT; AFRICAN AMERICANS; AGED; CARCINOGENESIS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; GENE SILENCING; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS;

EID: 84892807473     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2013.09.006     Document Type: Article

References (31)

1. Howlader N, Noone AM, Krapcho M, et al, editors. Table 20.20 cancer of oral cavity and pharynx by subsite (invasive). SEER Cancer Statistics Review, 1975-2010, National Cancer Institute. Bethesda, MD SEER; 2013. http://seer.cancer.gov/csr/1975-2010/, based on November 2012 SEER data submission, posted to the SEER web site April 2013, updated 14 June 2013, accessed 14 August 2013. http://seer.cancer.gov/csr/1975-2010/results-single/ sect-20-table.20.pdf.
2. M. Frisch, H. Hjalgrim, A.B. Jaeger, and R.J. Biggar Changing patterns of tonsillar squamous cell carcinoma in the United States Cancer Causes Control 11 2000 489 495
3. A.B. Ryerson, E.S. Peters, and S.S. Coughlin et al. Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998-2003 Cancer 113 2008 2901 2909
4. A.K. Chaturvedi, E.A. Engels, and R.M. Pfeiffer et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States J Clin Oncol 29 2011 4294 4301
5. K.R. Dahlstrom, K. Adler-Storthz, and C.J. Etzel et al. Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers Clin Cancer Res 9 2003 2620 2626
6. A.R. Kreimer, G.M. Clifford, and P. Boyle et al. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review Cancer Epidemiol Biomarkers Prev 14 2005 467 475
7. C.G. Hobbs, J.A. Sterne, and M. Bailey et al. Human papillomavirus and head and neck cancer: a systematic review and meta-analysis Clin Otolaryngol 31 2006 259 266
8. K.K. Ang, and E.M. Sturgis Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma Semin Radiat Oncol 22 2012 128 142
9. A. Jemal, E.P. Simard, and C. Dorell et al. Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus (HPV)-associated cancers and HPV vaccination coverage levels J Natl Cancer Inst 105 2013 175 201
10. J.W. Rainsbury, W. Ahmed, and H.K. Williams et al. Prognostic biomarkers of survival in oropharyngeal squamous cell carcinoma: systematic review and meta-analysis Head Neck 35 2013 1048 1055
11. M.A. O'Rorke, M.V. Ellison, and L.J. Murray et al. Human papillomavirus related head and neck cancer survival: a systematic review and meta-analysis Oral Oncol 48 2012 1191 1201
12. K. Settle, M.R. Posner, and L.M. Schumaker et al. Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients Cancer Prev Res 2 2009 776 781
13. A.R. Sedaghat, Z. Zhang, and S. Begum et al. Prognostic significance of human papillomavirus in oropharyngeal squamous cell carcinomas Laryngoscope 119 2009 1542 1549
14. C.C. Ragin, S.M. Langevin, M. Marzouk, J. Grandis, and E. Taioli Determinants of head and neck cancer survival by race Head Neck 33 2011 1092 1098
15. L.M. Chen, G. Li, and L.R. Reitzel et al. Matched-pair analysis of race or ethnicity in outcomes of head and neck cancer patients receiving similar multidisciplinary care Cancer Prev Res (Phila) 2 2009 782 791
16. C. Fakhry, W.H. Westra, and S. Li et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial J Natl Cancer Inst 100 2008 261 269
17. T.P. Schrank, Y. Han, H. Weiss, and V.A. Resto Case-matching analysis of head and neck squamous cell carcinoma in racial and ethnic minorities in the United States - possible role for human papillomavirus in survival disparities Head Neck 33 2011 45 53
18. N.F. Schlecht, M. Brandwein-Gensler, and G.J. Nuovo et al. A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer Mod Pathol 10 2011 1295 1305
19. R.D. Chernock, Q. Zhang, and S.K. El-Mofty et al. Human papillomavirus-related squamous cell carcinoma of the oropharynx: a comparative study in whites and African Americans Arch Otolaryngol Head Neck Surg 137 2011 163 169
20. J.L. St Guily, C. Clavel, and C. Okaïs et al. Human papillomavirus genotype distribution in tonsil cancers Head Neck Oncol 3 2011 6 10.1186/1758-3284-3-6
21. D.W. Kingma, R.A. Allen, and W. Moore et al. HPV genotype distribution in oral and oropharyngeal squamous cell carcinoma using seven in vitro amplification assays Anticancer Res 30 2010 5099 5104
22. T. Isayeva, N. Said-Al-Naif, and Z. Ren et al. Salivary mucoepidermoid carcinoma: demonstration of transcriptionally active human papillomavirus 16/18 Head Neck Pathol 7 2013 135 148
23. J.S. Lewis Jr., W.L. Thorstad, and R.D. Chernock et al. p16 positive oropharyngeal squamous cell carcinoma: an entity with a favorable prognosis regardless of tumor HPV status Am J Surg Pathol 34 2010 1088 1096
24. P. Lassen, J.G. Eriksen, and S. Hamilton-Dutoit et al. Effect of HPV-associated p16INK4a expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck J Clin Oncol 27 2009 1992
25. P. Lassen, J.G. Eriksen, and S. Hamilton-Dutoit et al. HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer Radiother Oncol 94 2010 30
26. K.K. Ang, J. Harris, and R. Wheeler et al. Human papillomavirus and survival of patients with oropharyngeal cancer N Engl J Med 363 2010 24 35
27. M.F. Calmon, J. Colombo, and F. Carvalho et al. Methylation profile of genes CDKN2A (p14 and p16), DAPK1, CDH1, and ADAM23 in head and neck cancer Cancer Genet Cytogenet 173 2007 31 37
28. J.L. Roh, V.X. Wang, and J. Manola et al. Clinical correlates of promoter hypermethylation of four target genes in head and neck cancer: a cooperative group correlative study Clin Cancer Res. 19 2013 2528 2540
29. J.P. Klussmann, J.J. Mooren, and M. Lehnen et al. Genetic signatures of HPV-related and unrelated oropharyngeal carcinoma and their prognostic implications Clin Cancer Res 15 2009 1779 1786
30. M. Hasegawa, H.H. Nelson, and E. Peters et al. Patterns of gene promoter methylation in squamous cell cancer of the head and neck Oncogene 21 2002 4231 4236
31. D.H. Kim, H.H. Nelson, and J.K. Wiencke et al. p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer Cancer Res 61 2001 3419 3424